000 01355 a2200349 4500
005 20250513102739.0
264 0 _c19970103
008 199701s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199627003-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMimran, A
245 0 0 _aAntihypertensive therapy and renal function.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_c1996
300 _aS19-25 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xpharmacology
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCalcium Channel Blockers
_xpharmacology
650 0 4 _aDiet, Sodium-Restricted
650 0 4 _aDiuretics
_xpharmacology
650 0 4 _aGlomerular Filtration Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypertension
_xphysiopathology
650 0 4 _aKidney
_xphysiology
650 0 4 _aRenal Circulation
_xdrug effects
773 0 _tJournal of cardiovascular pharmacology
_gvol. 27 Suppl 3
_gp. S19-25
856 4 0 _uhttps://doi.org/10.1097/00005344-199627003-00004
_zAvailable from publisher's website
999 _c8865029
_d8865029